These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12849880)
21. Efficacy of levetiracetam for neonatal seizures in preterm infants. Han JY; Moon CJ; Youn YA; Sung IK; Lee IG BMC Pediatr; 2018 Apr; 18(1):131. PubMed ID: 29636029 [TBL] [Abstract][Full Text] [Related]
22. [Neonatal convulsions: influence of the electroencephalographic pattern and the response to treatment on the outcome]. Doménech-Martínez E; Castro-Conde JR; Herraiz-Culebras T; González-Campo C; Méndez-Pérez A Rev Neurol; 2003 Sep 1-15; 37(5):413-20. PubMed ID: 14533087 [TBL] [Abstract][Full Text] [Related]
23. Adequacy of routine EEG examinations in neonates with clinically suspected seizures. Glauser TA; Clancy RR J Child Neurol; 1992 Apr; 7(2):215-20. PubMed ID: 1573242 [TBL] [Abstract][Full Text] [Related]
24. Spatial and temporal characteristics of neonatal seizures. Bye AM; Flanagan D Epilepsia; 1995 Oct; 36(10):1009-16. PubMed ID: 7555951 [TBL] [Abstract][Full Text] [Related]
25. Role of intravenous levetiracetam for acute seizure management in preterm neonates. Khan O; Cipriani C; Wright C; Crisp E; Kirmani B Pediatr Neurol; 2013 Nov; 49(5):340-3. PubMed ID: 23921284 [TBL] [Abstract][Full Text] [Related]
26. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. McBride MC; Laroia N; Guillet R Neurology; 2000 Aug; 55(4):506-13. PubMed ID: 10953181 [TBL] [Abstract][Full Text] [Related]
27. Neonatal seizure recurrence following discontinuation of phenobarbital. Labrecque D; Gal P; Sharpless MK Clin Pharm; 1984; 3(6):649-52. PubMed ID: 6509879 [TBL] [Abstract][Full Text] [Related]
28. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. Babaei A; Eslamai MH Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792 [TBL] [Abstract][Full Text] [Related]
33. Clinical and EEG response to anticonvulsants in neonatal seizures. Connell J; Oozeer R; de Vries L; Dubowitz LM; Dubowitz V Arch Dis Child; 1989 Apr; 64(4 Spec No):459-64. PubMed ID: 2730114 [TBL] [Abstract][Full Text] [Related]
34. Oral high-dose phenobarbital therapy for early infantile epileptic encephalopathy. Ozawa H; Kawada Y; Noma S; Sugai K Pediatr Neurol; 2002 Mar; 26(3):222-4. PubMed ID: 11955931 [TBL] [Abstract][Full Text] [Related]
35. Phenobarbitone versus phenytoin for treatment of neonatal seizures: an open-label randomized controlled trial. Pathak G; Upadhyay A; Pathak U; Chawla D; Goel SP Indian Pediatr; 2013 Aug; 50(8):753-7. PubMed ID: 23502660 [TBL] [Abstract][Full Text] [Related]
36. [Development of the electroencephalogram and the significance of neonatal convulsions in premature infants]. Lütschg J Monatsschr Kinderheilkd; 1986 Sep; 134(9):658-61. PubMed ID: 3097523 [TBL] [Abstract][Full Text] [Related]
37. Phenobarbital therapy in neonatal seizures and the prognostic value of the EEG. Staudt F; Scholl ML; Coen RW; Bickford RB Neuropediatrics; 1982 Feb; 13(1):24-33. PubMed ID: 7078705 [TBL] [Abstract][Full Text] [Related]
38. Rapid sequential phenobarbital treatment of neonatal seizures. Gilman JT; Gal P; Duchowny MS; Weaver RL; Ransom JL Pediatrics; 1989 May; 83(5):674-8. PubMed ID: 2717283 [TBL] [Abstract][Full Text] [Related]
39. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex. Whitney R; Jan S; Zak M; McCoy B Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505 [TBL] [Abstract][Full Text] [Related]
40. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Pressler RM; Boylan GB; Marlow N; Blennow M; Chiron C; Cross JH; de Vries LS; Hallberg B; Hellström-Westas L; Jullien V; Livingstone V; Mangum B; Murphy B; Murray D; Pons G; Rennie J; Swarte R; Toet MC; Vanhatalo S; Zohar S; Lancet Neurol; 2015 May; 14(5):469-77. PubMed ID: 25765333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]